Release date of six-month interim report (Q2) 2020 for ALK and audio cast

On Wednesday, 12 August 2020, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its six-month interim report (Q2) 2020.

ALK will host a meeting for analysts and institutional investors that day at 1.30 p.m. (CEST) at which Management will review the financial results, the outlook and answer questions.

The meeting will be audio cast live on our website https://ir.alk.net, where the related presentation will be available shortly before the meeting begins.

Participants in the conference call are kindly requested to call in before 1.25 p.m. (CEST). Danish participants should call in on tel. [phone] and international participants should call in on tel. [phone] or [phone]. Please use the Participant Pin Code: 73006317#.

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, tel. [phone], mobile [phone]
Media: Jeppe Ilkjær, mobile [phone]

About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,400 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.

Attachment

• InvestorNews_5Aug20